J Liu,
Q Liu,
Y Li,
Q Li, F Su, H Yao, S Su… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Previous trials showed that antiangiogenesis or anti-programmed death protein
1/programmed death ligand 1 (PD-1/PD-L1) monotherapy only showed marginal effect in …